| abstract |
The invention relates to a pharmaceutical preparation containing lerisetron and provided in the form of a transdermal therapeutic system (TTS). The inventive preparation comprises a backing layer, an active substance reservoir and a detachable protective layer. Said active substance reservoir is adhesive, has at least one layer, contains lerisetron, is joined to said backing layer, and is based on silicon adhesive(s). |